Please Wait...

Additional Therapeutic Areas

We have the deep experience you need
Bioclinica offers centralized medical imaging solutions coupled with deep scientific, regulatory, and medical expertise to adeptly support your clinical research across all major therapeutic areas including inflammatory disease, metabolic and gastroenterology indications. A thorough understanding of imaging modalities, endpoints and scoring systems allows us to assign scientific experts to match the needs of your study, from protocol design through to regulatory submission.

Bioclinica provides extensive knowledge and experience to the design and implementation of clinical trials for all major indications, including protocol and imaging charter development. We offer proven expertise supporting trials on some of the biggest drugs and biggest pharmaceutical companies. Yet we have the flexibility to scale up or down, providing customize support for all study sizes.

Studies across a wide range of indications
FDA-approved drugs
Years of Experience

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support your next trial.


Inflammatory Imaging Expertise

Autoimmune and Inflammatory diseases including Rheumatoid Arthritis (RA) affect millions of people each year. Research and development in this area continues to grow at a rapid pace evidenced by the emergence of new treatments being tested in clinical trials. Bioclinica medical affairs, technologists and operational teams have the experience necessary to deliver quality data and expert independent image review.

  • Determination of trial specific endpoints
  • Development (of imaging protocols and imaging charter
  • Design of independent review methodology
  • Delivery of high quality data

Bioclinica is proud to have contributed to the FDA-approval of novel therapeutics for the treatment of inflammatory diseases.

Drug Name Indication
Actemra Rheumatoid Arthritis
Cimzia Rheumatoid Arthritis
Enbrel Rheumatoid Arthritis
Humira Rheumatoid Arthritis
Kineret Rheumatoid Arthritis
Orencia Rheumatoid Arthritis
Pegloticase Gout
Remicade Rheumatoid Arthritis
Simponi Rheumatoid Arthritis

Metabolic and Endocrinology Services

Metabolic and endocrine disorders comprise a large number of complex and prevalent human diseases including diabetes and obesity. Advances in molecular biology and medicine have resulted in an increased understanding of metabolic diseases and innovations in the evaluation and treatment of metabolic syndromes.

Bioclinica has extensive experience in supporting safety and efficacy trials for metabolic and endocrinology indications, implementing the latest modalities and quantitative tools used for precise evaluation of imaging endpoints.

To deliver the highest quality image data and accurate independent review, Bioclinica offers a robust and customizable solution with unique features for metabolic and endocrinology trials including:

  • Sophisticated algorithms and analysis tools for quantitative measurements from QCT and DXA modalities
  • Precise muscle quantification and body composition measurements
  • Specific logic and edit checks based on trial specific endpoints
  • Automatic transfer of image analysis data into Electronic Case Report Forms (eCRFs)

Gastroenterology Expertise

Gastroenterology clinical research remains strong with regular testing of new treatments. Endoscopy plays a pivotal role in evaluating the efficacy and safety of new drugs for Inflammatory Bowel Disease (IBD) and determining patient eligibility for GI trials.

As a specialist provider of centralized medical image analysis, Bioclinica has the scientific and operational expertise to successfully support your GI clinical trial. Our therapeutically aligned KOLs, Operational teams, and Project Management combined with technology for endoscopic acquisition deliver high quality data and expert independent review.

Experience with prevalent GI indications:

  • Inflammatory Bowel Disease (IBD)
  • Ulcerative Colitis (UC)
  • Crohn's Disease
  • Fecal Incontinence
  • Primary Sclerosing Cholangitis (PSC)

Download GI Overview Sheet

Additional Major Therapeutic Areas Include

When you partner with Bioclinica, we provide you with a therapeutic medical imaging management specialty team to help coordinate all the functions of your imaging clinical trial data. This team includes not only our scientific staff and medical team, but also a network of world-renowned key opinion leaders and extensive roster of collaborative consultants. We have expertise in the broadest range of imaging modalities, more experience from over 2000+ imaging clinical trials and the process knowledge that can increase the efficiency and quality of your clinical trial.

  • Asthma

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Dermatology

  • Emphysema

  • Growth Hormone Deficiencies

  • Idiopathic Pulmonary Fibrosis

  • Sepsis

  • Infectious Disease

  • Lipodystrophy

  • Orthopedic Devices

  • Peripheral Vascular Disease (PVD)

  • Muscle-Wasting

  • Peridural Fibrosis

  • Body Composition (Obesity/Weight Loss)

  • Cystic Fibrosis Diagnostic Imaging

  • Deep Vein Thrombosis (DVT)

  • Gout

  • Human Immunodeficiency Virus (HIV)

  • Wound Healing

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.
bioclinica (13 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica
bioclinica (13 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner…
bioclinica (13 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: #ITTX17
bioclinica (13 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence,
bioclinica (13 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam
bioclinica (14 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices